National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 17658-17659 [2011-7499]

Download as PDF 17658 Federal Register / Vol. 76, No. 61 / Wednesday, March 30, 2011 / Notices III. What are the topics we intend to address at the public workshop? We intend to discuss a large number of issues at the workshop, including, but not limited to the following: • Establishment of the MDEpiNet infrastructure, • Gaps and challenges in medical device outcomes and epidemiologic studies, • Opportunities for medical device epidemiologic research and partnerships between the Center for Devices and Radiological Health and academia. IV. Where can I find out more about this public workshop? Background information on the public workshop, registration information, the agenda, information about lodging, and other relevant information will be posted, as it becomes available, on the Internet at https://fda-ws.s-3.net/ EpiNetWSApr11/. Dated: March 25, 2011. Leslie Kux, Acting Assistant Commissioner for Policy. [FR Doc. 2011–7434 Filed 3–29–11; 8:45 am] BILLING CODE 4160–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration National Forum for State and Territorial Chief Executives (National Forum) Program Cooperative Agreement Health Resources and Services Administration (HRSA), HHS. ACTION: Notice of Non-competitive OneYear Extension With Funds for the National Forum for State and Territorial Chief Executives (National Forum) Program Cooperative Agreement. Original Period of Support: April 1, 2008, to March 31, 2011. Amount of Supplement Award: $160,000. Authority: Sections 241 and 301 of the Public Health Service Act, as amended (42 U.S.C. 238J and 241 respectively). CFDA Number: 93.224. Justification for the Exception to Competition: The National Forum cooperative agreement provides a unique vehicle for HRSA to collaborate with the Nation’s governors on their shared priorities, and provides opportunities through which governors can build on lessons others states have learned in addressing similar health policy challenges. A 1-year extension with funds will allow the National Forum to facilitate ongoing communication on emerging strategies addressing common priorities, public health policy, and governance issues affecting States and Territories thereby allowing HRSA to reevaluate the focus and implementation of this Program prior to the FY 2012 competition for the next 3-year project period. Further funding beyond March 31, 2012, will be competitively awarded in FY 2012. FOR FURTHER INFORMATION CONTACT: Mark Pincus, Director, Office of Policy Analysis, HRSA, via e-mail: mpincus@hrsa.gov or via telephone: 301–443–5911. Dated: March 23, 2011. Mary K. Wakefield, Administrator. [FR Doc. 2011–7444 Filed 3–29–11; 8:45 am] BILLING CODE 4165–15–P AGENCY: HRSA will be providing a one-year extension with funds in the amount authorized in fiscal year (FY) 2010 to support activities that focus on cross-cutting publicly-funded health program integration and health access issues identified by the State and Territory governors and their senior health policy advisors, including addressing the needs of uninsured, underinsured and special needs populations, oral health, border health and health information technology as well as HRSA’s overall strategic goals. SUPPLEMENTARY INFORMATION: Cooperative Agreement Recipient of Record: National Governors Association Center for Best Practices (NGA), Washington, DC. WReier-Aviles on DSKGBLS3C1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 14:59 Mar 29, 2011 Jkt 223001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; NIDDK Central Repositories Non-Renewable Sample Access (X01)-Hepatitis C. Date: April 26, 2011. Time: 2 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call) Contact Person: Najma Begum, PhD, Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 749, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–8894, begumn@niddk.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: March 24, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–7500 Filed 3–29–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; ‘‘Mouse Resource’’. Date: April 20, 2011. Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call) Contact Person: Gregory P. Jarosik, PhD, Scientific Review Administrator, Scientific E:\FR\FM\30MRN1.SGM 30MRN1 Federal Register / Vol. 76, No. 61 / Wednesday, March 30, 2011 / Notices Review Program, Division of Extramural Activities, National Institutes of Health/ NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, (301) 496–0695, gjarosik@niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Immune Regulation and Tolerance. Date: May 9–10, 2011. Time: 11 a.m. to 6:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call) Contact Person: Lakshmi Ramachandra, PhD, Scientific Review Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 6700–B Rockledge Drive, MSC–7616, Room 3264, Bethesda, MD 20892–7616, 301–496– 2550, Ramachandral@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: March 24, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health WReier-Aviles on DSKGBLS3C1PROD with NOTICES Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel; Mentored PatientOriented Research Career Development Award. Date: April 27, 2011 . Time: 10 a.m. to 11:30 a.m. Agenda: To review and evaluate grant applications. Jkt 223001 [FR Doc. 2011–7498 Filed 3–29–11; 8:45 am] 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: March 24, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–7496 Filed 3–29–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Complementary and Alternative Medicine Announcement of Stakeholder Roundtable BILLING CODE 4140–01–P ACTION: DEPARTMENT OF HEALTH AND HUMAN SERVICES Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting BILLING CODE 4140–01–P 14:59 Mar 29, 2011 Dated: March 24, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. National Institutes of Health [FR Doc. 2011–7499 Filed 3–29–11; 8:45 am] VerDate Mar<15>2010 Place: National Institutes of Health, 6100 Executive Boulevard, Rockville, MD 20852 (Telephone Conference). Contact Person: Anne Krey, PhD, Scientific Review Officer, Division of Scientific Review, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, 6100 Executive Blvd., Room 5B01, Bethesda, MD 20892, 301–435– 6908, kreya@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) 17659 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel; NIH Summer Research Experience Program. Date: April 20, 2011. Time: 10 a.m. to 12 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6100 Executive Boulevard, Rockville, MD 20852 (Telephone Conference). Contact Person: Anne Krey, PhD, Scientific Review Officer, Division of Scientific Review, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, 6100 Executive Blvd., Room 5B01, Bethesda, MD 20892, 301–435– 6908, kreya@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 Notice. The National Center for Complementary and Alternative Medicine (NCCAM) invites the public to a Stakeholder Roundtable. Attendees will meet the NCCAM Director and discuss the Center’s new strategic plan, activities, and priorities. The Roundtable will take place: 8:30 a.m.–11 a.m., Tuesday, April 26, 2011, Building 31, 6C, Room 10, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD. To allow for meaningful interaction, space is limited. To attend, please RSVP by Friday, April 1, 2011, by contacting Carina May at 301–915–9763 or cmay@thehillgroup.com. Representatives from professional medical societies as well as consumer organizations are particularly encouraged to attend. Background: The National Center for Complementary and Alternative Medicine (NCCAM) was established in 1999. The mission of NCCAM is to define, through rigorous scientific investigation, the usefulness and safety of complementary and alternative medicine interventions and their roles in improving health and health care To date, NCCAM’s efforts to meet its mission have been guided by NCCAM’s strategic plans located on the NCCAM Web site at https://nccam.nih.gov/about/ plans/. Request for Participation: Representatives of stakeholder organizations are invited to provide input into the NCCAM’s priorities and activities at a Stakeholder Roundtable. This event will give NCCAM stakeholders an opportunity to voice their opinions regarding future directions for research, training, outreach, and integration in SUMMARY: E:\FR\FM\30MRN1.SGM 30MRN1

Agencies

[Federal Register Volume 76, Number 61 (Wednesday, March 30, 2011)]
[Notices]
[Pages 17658-17659]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-7499]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; ``Mouse Resource''.
    Date: April 20, 2011.
    Time: 1 p.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6700B Rockledge Drive, 
Bethesda, MD 20817, (Telephone Conference Call)
    Contact Person: Gregory P. Jarosik, PhD, Scientific Review 
Administrator, Scientific

[[Page 17659]]

Review Program, Division of Extramural Activities, National 
Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7616, 
Bethesda, MD 20892, (301) 496-0695, gjarosik@niaid.nih.gov.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Immune Regulation and Tolerance.
    Date: May 9-10, 2011.
    Time: 11 a.m. to 6:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6700B Rockledge Drive, 
Bethesda, MD 20817, (Telephone Conference Call)
    Contact Person: Lakshmi Ramachandra, PhD, Scientific Review 
Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 6700-B 
Rockledge Drive, MSC-7616, Room 3264, Bethesda, MD 20892-7616, 301-
496-2550, Ramachandral@niaid.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: March 24, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-7499 Filed 3-29-11; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.